Kristin Stephens - Apr 1, 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Chief Development Officer
Signature
/s/ Kristin Stephens
Stock symbol
SYRS
Transactions as of
Apr 1, 2022
Transactions value $
-$15,809
Form type
4
Date filed
4/4/2022, 05:04 PM
Previous filing
Feb 17, 2022
Next filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Tax liability -$15.8K -14.1K -31.37% $1.12 30.9K Apr 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares used to cover tax withholding on a Restricted Stock Unit release.